NCT00354991View on ClinicalTrials.gov

Hyzaar Asia HEAALTH (0954A-950)

PHASE3CompletedINTERVENTIONAL

Enrollment

437

Participants

Timeline

Start Date

June 1, 2006

Primary Completion Date

April 1, 2007

Study Completion Date

April 1, 2007

Conditions

Hypertension

Interventions

DRUG

losartan potassium (+) hydrochlorothiazide

Patients took losartan 50 mg /HCTZ 12.5 mg orally once daily for 13 weeks. At Weeks 0, 4 and 8 if the blood pressure goal was not reached then the losartan/HCTZ combination will be titrated upwards according to the following scheme: losartan 50/HCTZ 12.5 to losartan 100/HCTZ 12.5 to losartan 100/HCTZ 25.

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00354991 - Hyzaar Asia HEAALTH (0954A-950) | Biotech Hunter | Biotech Hunter